Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review

ConclusionEarly evidence suggests that dapagliflozin and empagliflozin are well tolerated in children. A clinical pharmacology rationale currently exists only for adolescents with diabetes mellitus.Prospero Registration NumberCRD42023438162.
Source: Pediatric Drugs - Category: Pediatrics Source Type: research